Insulin-Heparin Infusions Peritransplant Substantially Improve Single-Donor Clinical Islet Transplant Success
- 27 February 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 89 (4), 465-471
- https://doi.org/10.1097/tp.0b013e3181c478fd
Abstract
Successful islet transplantation can result in insulin independence in many patients with type 1 diabetes mellitus, but it often requires more than one islet infusion. The ability to achieve insulin independence with a single donor is an important goal in clinical islet transplantation due to the limited organ supply. We examined factors that may be associated with insulin independence after islet transplantation with islets from a single donor, using univariate and multivariate analysis. Thirteen of 85 (15.3%) achieved insulin independence after single-donor islet transplantation. Using multivariate analysis, only the use of insulin and heparin infusions peritransplant was a significant factor associated with insulin independence, with an adjusted odds ratio of 8.6 (95% confidence interval 2.0-37.0). Patients who had received insulin and heparin infusions peritransplant had greater indices of islet engraftment and a greater reduction in insulin use (80.1%±4.3% vs. 54.2%±2.8%, P<0.001) even if insulin independence was not achieved. Peritransplant intensive insulin and heparin enhances islet transplantation outcomes likely related in part to mitigation of the effects of the instant blood-mediated inflammatory reaction, combined with islet rest and avoidance of inflammation. It would be important to further investigate the effects of peritransplant insulin and heparin infusions on islet engraftment.Keywords
This publication has 26 references indexed in Scilit:
- Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet TransplantationDiabetes, 2007
- International Trial of the Edmonton Protocol for Islet TransplantationNew England Journal of Medicine, 2006
- Low Molecular Weight Dextran Sulfate: A Strong Candidate Drug to Block IBMIR in Clinical Islet TransplantationAmerican Journal of Transplantation, 2006
- Simple Evaluation of Engraftment by Secretory Unit of Islet Transplant Objects for Living Donor and Cadaveric Donor Fresh or Cultured Islet TransplantationTransplantation Proceedings, 2005
- Five-Year Follow-Up After Clinical Islet TransplantationDiabetes, 2005
- Single-Donor, Marginal-Dose Islet Transplantation in Patients With Type 1 DiabetesJAMA, 2005
- β-Cell Function Following Human Islet Transplantation for Type 1 DiabetesDiabetes, 2005
- Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet TransplantationDiabetes, 2004
- Successful Islet TransplantationDiabetes, 2002
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000